• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Treatment outcomes of mantle cell lymphoma in real-world practice: analysis of forty-one patients.真实世界中套细胞淋巴瘤的治疗结果：41例患者分析
J Clin Exp Hematop. 2023;63(3):205-208. doi: 10.3960/jslrt.23024.
2
High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial.高剂量阿糖胞苷联合利妥昔单抗用于高增殖性套细胞淋巴瘤一线治疗不足：北欧淋巴瘤组套细胞淋巴瘤5试验提前终止
Leuk Lymphoma. 2014 May;55(5):1206-8. doi: 10.3109/10428194.2013.825906. Epub 2013 Aug 28.
3
Guideline for the management of mantle cell lymphoma.套细胞淋巴瘤管理指南。
Br J Haematol. 2018 Jul;182(1):46-62. doi: 10.1111/bjh.15283. Epub 2018 May 16.
4
Mantle cell lymphoma with uveal metastasis.伴有葡萄膜转移的套细胞淋巴瘤。
Leuk Lymphoma. 2010 Jul;51(7):1354-5. doi: 10.3109/10428194.2010.486093.
5
Sister Mary Joseph nodule in mantle cell lymphoma.套细胞淋巴瘤中的玛丽·约瑟夫修女结节。
Lancet Oncol. 2020 Jun;21(6):e337. doi: 10.1016/S1470-2045(20)30203-5.
6
Primary gastrointestinal mantle cell lymphoma: a retrospective study.原发性胃肠道套细胞淋巴瘤：一项回顾性研究。
J Gastrointest Cancer. 2014 Dec;45(4):481-6. doi: 10.1007/s12029-014-9655-2.
7
Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma.硼替佐米联合利妥昔单抗和地塞米松是复发和化疗耐药套细胞淋巴瘤患者的有效治疗方案。
Haematologica. 2011 Jul;96(7):1008-14. doi: 10.3324/haematol.2011.041392. Epub 2011 Apr 12.
8
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.在套细胞淋巴瘤和惰性淋巴瘤中成功进行含CD34外周血采集的体内净化：化疗和利妥昔单抗输注作用的证据
Blood. 2000 Aug 1;96(3):864-9.
9
Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study.依维莫司用于不适宜接受强化治疗的套细胞淋巴瘤患者的维持治疗：一项提前终止的2期研究结果
Leuk Lymphoma. 2015;56(11):3227-9. doi: 10.3109/10428194.2015.1028055. Epub 2015 Mar 31.
10
R-CHOP for mantle cell lymphoma.利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松（R-CHOP）方案治疗套细胞淋巴瘤
J Clin Oncol. 2005 Sep 20;23(27):6802; author reply 6802-3. doi: 10.1200/JCO.2005.02.3176.

本文引用的文献

1
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020.利妥昔单抗时代套细胞淋巴瘤患者的生存情况：2000年至2020年的回顾性双边分析。
Br J Haematol. 2023 Apr;201(1):64-74. doi: 10.1111/bjh.18597. Epub 2022 Dec 13.
2
Outcomes for Recurrent Mantle Cell Lymphoma Post-Ibrutinib Therapy: A Retrospective Cohort Study from a Japanese Administrative Database.伊布替尼治疗后复发套细胞淋巴瘤的结局：来自日本行政数据库的回顾性队列研究。
Adv Ther. 2022 Oct;39(10):4792-4807. doi: 10.1007/s12325-022-02258-3. Epub 2022 Aug 19.
3
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3.北欧套细胞淋巴瘤试验（MCL2和MCL3）后复发患者的详细长期随访
Hemasphere. 2020 Dec 21;5(1):e510. doi: 10.1097/HS9.0000000000000510. eCollection 2021 Jan.
4
Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!原始滤泡性和多形性套细胞淋巴瘤：仍然是诊断和治疗的挑战！
Blood. 2018 Dec 27;132(26):2722-2729. doi: 10.1182/blood-2017-08-737502. Epub 2018 Nov 1.
5
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.不适合移植的新诊断套细胞淋巴瘤患者中硼替佐米、利妥昔单抗、环磷酰胺、多柔比星、泼尼松（VR-CAP）与利妥昔单抗、环磷酰胺、多柔比星、长春新碱、泼尼松（R-CHOP）的比较：一项随机、开放标签、3 期研究的最终总生存结果。
Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19.
6
R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.在新诊断的套细胞淋巴瘤中采用 R-High-CHOP/CHASER/LEED 联合自体干细胞移植：JCOG0406 研究。
Cancer Sci. 2018 Sep;109(9):2830-2840. doi: 10.1111/cas.13719. Epub 2018 Jul 28.
7
Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.在欧洲套细胞淋巴瘤网络的试验中，TP53 的表达与 MIPI 和 Ki-67 无关，与 MCL 的预后相关。
Blood. 2018 Jan 25;131(4):417-420. doi: 10.1182/blood-2017-07-797019. Epub 2017 Dec 1.
8
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.依鲁替尼对比替西罗莫司治疗复发或难治性套细胞淋巴瘤患者：一项国际性、随机、开放标签、3 期研究。
Lancet. 2016 Feb 20;387(10020):770-8. doi: 10.1016/S0140-6736(15)00667-4. Epub 2015 Dec 7.
9
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.霍奇金淋巴瘤和非霍奇金淋巴瘤初始评估、分期及反应评估的建议：卢加诺分类
J Clin Oncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800.
10
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.苯达莫司汀联合利妥昔单抗与 CHOP 联合利妥昔单抗作为惰性和套细胞淋巴瘤患者一线治疗的比较：一项开放标签、多中心、随机、3 期非劣效性临床试验。
Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20.

Treatment outcomes of mantle cell lymphoma in real-world practice: analysis of forty-one patients.

作者信息

Saburi Masuho, Kodama Yosuke, Uraisami Keiichi, Takata Hiroyuki, Miyazaki Yasuhiko, Nishikawa Takumi, Sasaki Hitohiro, Abe Miyuki, Kohno Kazuhiro, Wada Junpei, Urabe Shogo, Kondo Yoshiyuki, Nakayama Toshiyuki, Ohtsuka Eiichi

机构信息

Department of Hematology, Oita Prefectural Hospital, Oita, Japan.

Department of Hematology, Oita Kouseiren Tsurumi Hospital, Oita, Japan.

出版信息

J Clin Exp Hematop. 2023;63(3):205-208. doi: 10.3960/jslrt.23024.

DOI:10.3960/jslrt.23024
PMID:37766565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10628821/
Abstract
摘要